This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Niantic, CT (US) (1977)
- Waterford, CT (US) (1977)
Company Filing History:
Years Active: 1977
Title: The Innovations of James R. Tretter
Introduction
James R. Tretter is an accomplished inventor based in Niantic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bronchodilators and tranquilizing agents. With a total of 2 patents, Tretter's work has had a notable impact on medical science.
Latest Patents
Tretter's latest patents include the following:
1. **2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin** - This patent details the maleic acid salt of the compound and its preparation. It is used as an intermediate for making 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl)pyridine, which serves as an effective bronchodilator.
2. **5-Aryl-1,2,3,4-tetrahydro-.gamma.-carbolines** - This patent focuses on 2-substituted-5-aryl-1,2,3,4-tetrahydro-.gamma.-carbolines and their use as tranquilizing agents. It also covers the preparation of these compounds from 5-aryl-1,2,3,4-tetrahydro-.gamma.-carbolines.
Career Highlights
James R. Tretter is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to innovative solutions in healthcare.
Collaborations
Tretter has worked alongside notable colleagues such as Ronnie D. Carroll and Bernard S. Moore. Their combined expertise has fostered a collaborative environment that encourages groundbreaking research and development.
Conclusion
James R. Tretter's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of important medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
